白蛋白尿变化与终末期肾病及死亡后续风险相关
本研究基于瑞典斯德哥尔摩SCREAM项目观察性队列,纳入31732例有两次以上门诊尿白蛋白肌酐比(ACR)检测的个体,评估基线1、2或3年内ACR变化与终末期肾病(ESRD)或死亡的关系。2年基线期分析显示,随访中位3年间发生378例ESRD和1712例死亡;ACR升高4倍与ESRD风险升高相关,ACR降低4倍与ESRD风险降低相关,ACR变化与死亡关联较弱。
要点
- ACR升高4倍与ESRD风险升高相关(风险约为稳定ACR者的3.08倍)。
- ACR降低4倍与ESRD风险降低相关(风险约为稳定ACR者的0.34倍)。
- ACR变化与死亡的关联较弱,ACR降低时关系基本平坦。
核心结论
- 白蛋白尿变化与ESRD和死亡风险呈强烈且一致的关联。
研究设计与样本
- 观察性研究,来自瑞典斯德哥尔摩SCREAM(Stockholm CREAtinine Measurements)项目健康照护利用队列,实验室数据为2006-2011年,随访至2012年12月。
- 纳入31732例有两次或以上门诊尿白蛋白肌酐比(ACR)检测的个体,评估基线1年、2年或3年期间ACR变化与ESRD或死亡的关联。
主要发现
- 采用2年基线期,随访中位3年期间发生378例ESRD事件和1712例死亡。
- 与稳定ACR相比,ACR升高4倍与ESRD风险升高相关(风险为3.08倍,95%CI 2.59至3.67)。
- 与稳定ACR相比,ACR降低4倍与ESRD风险降低相关(风险为0.34倍,95%CI 0.26至0.45)。
- 在伴或不伴糖尿病、伴或不伴高血压人群中均发现相似关联,校正同期eGFR变化后结果仍相似。
- ACR变化与死亡的关联较弱:ACR升高与死亡相关,但ACR降低时关系基本平坦;1年、2年和3年ACR变化结果一致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Current guidelines for chronic kidney disease (CKD) recommend using albuminuria as well as estimated glomerular filtration rate (eGFR) to stage CKD. However, CKD progression is solely defined by change in eGFR with little regard to the risk implications of change in albuminuria. This is an observational study from the Stockholm CREAtinine Measurements (SCREAM) project, a health care utilization cohort from Stockholm, Sweden, with laboratory measures from 2006-2011 and follow-up through December 2012. Included were 31,732 individuals with two or more ambulatory urine albumin to creatinine ratio (ACR) tests. We assessed the association between change in ACR during a baseline period of 1, 2, or 3 years and end-stage renal disease (ESRD) or death. Using a 2-year baseline period, there were 378 ESRD events and 1712 deaths during a median of 3 years of follow-up. Compared to stable ACR, a 4-fold increase in ACR was associated with a 3.08-times (95% confidence interval 2.59 to 3.67) higher risk of ESRD while a 4-fold decrease in ACR was associated with a 0.34-times (0.26 to 0.45) lower risk of ESRD. Similar associations were found in people with and without diabetes mellitus, with and without hypertension, and also when adjusted for the change in eGFR during the same period. The association between change in ACR and mortality was weaker: ACR increase was associated with mortality, but the relationship was largely flat for ACR decline. Results were consistent for 1-, 2-, and 3-year ACR changes. Thus, changes in albuminuria are strongly and consistently associated with the risk of ESRD and death.
引用
- Carrero JJ, Grams ME, Sang Y, et al. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int. 2016. PMID: 27927597. doi:10.1016/j.kint.2016.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。